EGF and breast cancer: MacLeod et al. generated an Ad5 vector in which the epidermal growth factor (EGF)-like domain of heregulin-α was inserted into the HI loop to increase the in vitro infection of HER3/ErbB3- and HER4/ErbB4-expressing breast cancer cells [56].